Skip to main content
Log in

The significance of relationship of the presence of nonspecific suppressor cells in spleens with gastric cancer-related pathology

  • Original Articles
  • Published:
The Japanese journal of surgery Aims and scope Submit manuscript

Abstract

Lymphocyte-rich monomuclear cells (MC) were prepared from spleens removed at the time of surgery for gastric cancer and the suppressor cell activity on autochthonous peripheral blood lymphocyte (PBL) responses to PHA-P and Con A was assessed. Suppressor cell activity of MC on PBL responses to at least one mitogen, either PHA-P or Con A, was observied in 52 percent (11/21) of the gastric tissues studied. MC of patients with state IV disease appeared to exhibit the highest frequency of the presence of the activity. MC of patients with cancer with microscopically proven metastasis to group 2 lymph nodes or to more distant lymph nodes were preponderant in showing the activity. MC of patients with cancer occupying the greater curvature or the entire circumference of the stomach were also preponderant in the activity. The implications of these findings are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kanai, H. Significance of pancreatosplenectomy in gastric resection for gastric cancer. Nippon Gan Chiryo Gakkai Shi (J Jpn Soc Cancer Ther) 1967; 2: 328–338. (English Abst.)

    Google Scholar 

  2. Orita K, Konaga E, Okada T, Kunisada K, Yumura M, Tanaka S. Effect of splenectomy in tumor bearing mice and gastric cancer patients. Gann 1977; 68: 731–736.

    PubMed  CAS  Google Scholar 

  3. Watanabe T, Sakuma A. A clinicopathological study on the upper gastric cancer with special reference to the choice of operative procedure. Nippon Geka Gakkai Zasshi (J Jpn Soc Surg) 1977; 78: 395–407. (English Abst.)

    Google Scholar 

  4. Nishioka B, Watanabe S, Fujita Y, Mizuno M, Majima S. Evaluation of resection of stomach and adjacent organs for advanced gastric cancer with special reference to splenectomy and pancreaticosplenectomy. Nippon Shokaki Geka Gakkai Zashi (Jpn J Gastroenterol Surg) 1979; 12: 955–960. (in Japanese)

    Google Scholar 

  5. Yoshino K, Haruyama K, Nakamura S, Matsumoto S, Yamada Y, Isobe K, Kubota T, Kumai K, Ishibiki K, Abe O. Evaluation of splenectomy for gastric cancer. Nippon Shokaki Geka Gakkai Zashi (Jpn J Gastroenterol Surg) 1979; 12: 944–949. (in Japanese)

    Google Scholar 

  6. Sugimachi K, Kodama Y, Kumashiro R, Kanematsu T, Noda S, Inokuchi K. Critical evaluation of prophylactic’ splenectomy in total gastectomy for stomach cancer. Gann 1980; 71: 704–709.

    PubMed  CAS  Google Scholar 

  7. Koga S, Kaibara N, Kimura O, Nishidoi H, Kishimoto H. Prognostic significance of combined splenectomy or pancreaticosplenectomy in total or proximal gastrectomy for gastric cancer. Amer J Surg 1981; 142: 546–550.

    Article  PubMed  CAS  Google Scholar 

  8. Douglass HO. Potentially curable cancer of the stomach. Cancer 1982; 50: 2582–2589.

    PubMed  Google Scholar 

  9. Toge T, Hamamoto S, Itagaki E, Nakane H, Yajima K, Hattori T. Analysis of suppressor cell activities in spleen cells from gastric cancer patients and the effect of splenectomy on prognosis of gastric cancer. Nippon Geka Gakkai Zashi (J Jpn Soc Surg) 1983; 84: 961–964. (English Abst.)

    CAS  Google Scholar 

  10. Lockwood CM Immunological functions of the spleen. Clin in Hematol 1983; 12: 449–465.

    CAS  Google Scholar 

  11. Kurosu Y, Fukamachi S, Honda T, Morita K. Effect of spleen-derived cells on autochthonous peripheral blood lymphocyte responses to mitogens in gastric cancer patients. Gann 1982; 73: 805–810.

    PubMed  CAS  Google Scholar 

  12. Japanese Research Society for Gastric Cancer. General rules for the gastric cancer study in surgery. Jpn J Surg 1973; 3: 61–71.

    Article  Google Scholar 

  13. Naor D. Suppressor cells: Permitters and promoters of malignancy? Adv Cancer Res 1979; 29: 45–125.

    Article  PubMed  CAS  Google Scholar 

  14. Broder S, Waldmann TA. The suppressor-cell network in cancer (First of two parts). N Engl J Med 1978; 299: 1281–1284.

    Article  PubMed  CAS  Google Scholar 

  15. Broder S, Waldmann TA. The suppressor-cell network in cancer (Second of two parts). N Eng J Med 1978; 299: 1335–1341.

    Article  CAS  Google Scholar 

  16. Quan PC, Burtin P. Demonstration of nonspecific suppressor cells in the peripheral lymphocytes of cancer patients. Cancer Res 1978; 38: 288–296.

    PubMed  CAS  Google Scholar 

  17. Jerrells TR, Dean JH, Richardson GL, McCoy JL, Herberman RB. Role of suppressor cells in depression of in vitro lymphoproliferative responses of lung cancer and breast cancer patients. J Natl Cancer Inst 1978; 61: 1001–1009.

    PubMed  CAS  Google Scholar 

  18. Catalona WJ, Ratliff TL, McCool RE. Concanavalin A-inducible suppressor cells in regional lump nodes of cancer patients. Cancer Res 1979; 39: 4372–4377.

    PubMed  CAS  Google Scholar 

  19. Herr HW. Suppressor cells in the pelvic lymph nodes regional t bladder cancer. J Surg Oncol 1979; 11: 289–293.

    PubMed  CAS  Google Scholar 

  20. Sampson D, Kauffman HM, Grotelueschen C, Metzig J. Suppressor activity of the human spleen and thymus. Surgery 1976; 79: 393–397.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kurosu, Y., Fukamachi, S. & Morita, K. The significance of relationship of the presence of nonspecific suppressor cells in spleens with gastric cancer-related pathology. The Japanese Journal of Surgery 14, 293–298 (1984). https://doi.org/10.1007/BF02469644

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02469644

Key Words

Navigation